Aptadir Therapeutics

Aptadir Therapeutics is a Milan-based biotech company focused on novel treatments for genetic conditions.

Current treatments for many genetic diseases are limited or ineffective.

Aptadir develops innovative therapies targeting difficult-to-treat genetic conditions.

Patients with genetic diseases and pharmaceutical companies seeking new treatments.

Revenue generated through drug development partnerships and licensing agreements.

Raised $45 million in seed funding for drug development and clinical trials.

该维度暂无可核实信息（unknown）

Increasing demand for effective treatments for genetic diseases and advancements in biotech.